Global Spinal Stenosis Treatment Market – Industry Trends and Forecast to 2030

Spinal Stenosis Treatment Market Analysis and Size

Major factors that are expected to boost the growth of the global spinal stenosis treatment market in the forecast period 2023-2030 are the rise in the geriatric population. Furthermore, the growing obese population that are suffering from spine deformities is further anticipated to propel the growth of the global spinal stenosis treatment market. Moreover, the growing incidence of spinal disorders including degenerative scoliosis and degenerative spondylolisthesis is further estimated to cushion the growth of the global spinal stenosis treatment market. On the other hand, the growing cost of surgical treatment is further projected to impede the growth of the global spinal stenosis treatment market in the timeline period 2023-2030.                       

Data Bridge Market Research analyses that the global spinal stenosis treatment market which was USD 9.45 billion in 2022 is expected to reach USD 13.54 billion by 2030, and is expected to undergo a CAGR of 4.60% during the forecast period 2023-2030. This indicates that the market value. “Surgery” dominates the treatment segment of the global spinal stenosis treatment market owing to an increase in the number of spinal surgeries. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Spinal Stenosis Treatment Market Scope and Segmentation

Market Definition

Spinal stenosis is a medical condition characterized by the narrowing of the spinal canal or nerve openings in the spine, leading to pressure on the spinal cord or nerves. It typically occurs in the lower back (lumbar spinal stenosis) or neck (cervical spinal stenosis) and can cause symptoms such as pain, numbness, weakness, and difficulty walking. Treatment options range from conservative approaches like physical therapy and medications to surgical interventions like laminectomy or spinal fusion, depending on the severity of the condition and individual patient needs.

Global Spinal Stenosis Treatment Market Dynamics

Drivers

• Change in Lifestyle Habits

Lifestyle factors such as sedentary behavior, obesity, and poor posture have been associated with an increased risk of developing spinal stenosis. As these factors continue to impact a significant portion of the population, there is a growing need for both preventive measures and treatment options, driving the demand for spinal stenosis treatment.

• Technological Advancements

Advances in medical technology, including minimally invasive surgical techniques, improved imaging modalities, and the development of innovative spinal implants and devices, have expanded the range of treatment options for spinal stenosis. These advancements are driving market growth by offering more effective and less invasive treatment choices.

• Increasing Awareness and Diagnosis 

Increased awareness of spinal stenosis among healthcare professionals and patients, along with improved diagnostic capabilities, has led to earlier and more accurate diagnoses. This has resulted in a higher number of individuals seeking treatment for the condition, contributing to market expansion.

• Aging Population and Disease burden

The global population is aging, leading to a higher prevalence of spinal stenosis as it is commonly associated with age-related degenerative changes. As the elderly population increases, the demand for spinal stenosis treatment options, both non-surgical and surgical, is expected to grow.  

Opportunities

• Increased Demand for Minimally Invasive Procedures

The demand for minimally invasive surgical techniques, such as endoscopic spine surgery and minimally invasive decompression, is increasing. These procedures offer faster recovery times, reduced post-operative pain, and shorter hospital stays. There is a significant opportunity for companies to develop and market advanced minimally invasive technologies for spinal stenosis treatment.

• Telemedicine and Remote Monitoring

The adoption of telemedicine and remote patient monitoring has accelerated, offering opportunities for providing ongoing care and monitoring for individuals with spinal stenosis. Telehealth solutions, combined with wearable devices and remote monitoring platforms, can improve patient management and adherence to treatment plans while reducing healthcare costs.

Restraints/Challenges

• High Treatment Costs

The cost of spinal stenosis treatment, particularly surgical interventions and advanced medical devices, can be prohibitively high for many patients. This financial barrier can limit access to treatment options and restrain market growth, especially in regions with inadequate healthcare coverage.

• Stringent Regulatory Approvals

Regulatory approval for new medical devices and treatments in the spinal stenosis market can be a lengthy and costly process. Stringent regulatory requirements and clinical trials may slow down the introduction of innovative therapies and devices, hampering market growth.

• Limited insurance coverage

In some healthcare systems, insurance coverage for spinal stenosis treatment may be limited or not comprehensive. Patients may face difficulties in obtaining reimbursement for necessary procedures, which can discourage them from seeking treatment or opting for less expensive alternatives.

• Potential complications

Spinal stenosis treatments, especially surgical procedures, carry risks of complications and adverse events. Concerns about potential complications, such as infection or nerve damage, may deter some patients from undergoing treatment, leading to underutilization of available therapies.

This global spinal stenosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global spinal stenosis treatment market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In January 2022, Food and Drug Administration approved new expanded magnetic resonance imaging (MRI) compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode Leads
• In July 2022, Calyx and Qynapse have joined forces to expand the use of artificial intelligence (AI)-based neuroimaging tools in clinical trials of treatment candidates for conditions affecting the central nervous system (CNS), or the brain and spinal cord

Global Spinal Stenosis Treatment Market Scope

The global spinal stenosis treatment market is segmented on the basis of type, treatment, drugs class, drugs, route of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Cervical stenosis
• Lumbar stenosis

Treatment

• Synthetic material
• Biologically derived material
• Genetically engineered material
• Pharmaceutical

Drug Class

• Analgesics
• Antidepressants
• Anti-seizures
• Corticosteroid
• Others

Drugs

• Naproxen
• Amitriptyline
• Gabapentin
• Oxycodone
• Others

Route of Administration

• Oral
• Intravenous
• Intraspinal
• Others

Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

End User

• Hospitals
• Homecare
• Specialty clinics
• Others.

Global Spinal Stenosis Treatment Market Regional Analysis/Insights

The global spinal stenosis treatment market is analysed and market size insights and trends are provided by country, type, treatment, drugs class, drugs, route of administration, distribution channel and end user as referenced above.

The countries covered in the global spinal stenosis treatment market report are U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the global spinal stenosis treatment market due to the rise in the aging population. Furthermore, the occurrence of major key players will further boost the growth of the global spinal stenosis treatment market in the region during the forecast period 2023-2030. Asia-Pacific is projected to observe significant amount of growth in the global spinal stenosis treatment market due to the increase in the geriatric population. Moreover, the rise in the number of hospitals that are offering surgical treatment for spinal stenosis and increasing health care expenses is further anticipated to propel the growth of the global spinal stenosis treatment market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global spinal stenosis treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global spinal stenosis treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global spinal stenosis treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Spinal Stenosis Treatment Market Share Analysis

The global spinal stenosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global spinal stenosis treatment market.

Some of the major players operating in the global spinal stenosis treatment market are:

• Mallinckrodt (U.K.)
• Yungjin Pharm (South Korea)
• Ono Pharmaceutical Co., Ltd (Japan)
• Sumitomo Dainippon Pharma Co., Ltd (Japan)
• NIPPON SHINYAKU CO., LTD (Japan)
• Taisho Pharmaceuticals Co., Ltd (Japan)
• RTI Surgical Holdings, Inc (U.S.)
• Medtronic (Ireland)
• Johnson & Johnson Services, Inc (U.S.)
• Empirical Spine, Inc (U.S.)
• Alphatec Spine, Inc (U.S.)
• B. Braun Melsungen AG (Germany)
• Exactech, Inc (U.S.)
• Globus Medical Inc (U.S.)
• NuVasive, Inc (U.S.)
• Orthofix Holdings, Inc (U.S.)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• Pfizer Inc (U.S.)
• Vertos Medical Inc (U.S.)
• Endo Pharmaceuticals Inc (Ireland)  

SKU-50477